APLNR and glioblastoma: In summary, whilst we have not examined molecular mechanisms underlying apelin receptor signalling in GBM in this study, we present a descriptive analysis of receptor and ligand expression in the vasculature, GSCs, and the four key cell types that drive GBM tumour proliferation, invasiveness, maintenance, and resistance to current therapies.